Doheny Asset Management /Ca Fate Therapeutics Inc Transaction History

Doheny Asset Management /Ca

$146 Million
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	BUY	$3.26 - $7.08 $25,004 - $54,303	7,670 New	7,670 $25,000
Q3 2022 Nov 10, 2022	SELL	$21.04 - $36.06 $121,611 - $208,426	-5,780 Closed	0 $0
Q4 2021 Feb 15, 2022	SELL	$47.84 - $64.34 $21,528 - $28,953	-450 Reduced 7.22%	5,780 $338,000
Q3 2021 Oct 22, 2021	SELL	$59.27 - $95.73 $27,856 - $44,993	-470 Reduced 7.01%	6,230 $369,000
Q1 2021 May 17, 2021	SELL	$72.16 - $117.4 $82,984 - $135,010	-1,150 Reduced 14.65%	6,700 $552,000
Q4 2020 Feb 26, 2021	SELL	$38.09 - $100.95 $622,771 - $1.65 Million	-16,350 Reduced 67.56%	7,850 $714,000
Q3 2020 Nov 12, 2020	BUY	$30.41 - $40.5 $502,677 - $669,465	16,530 Added 215.51%	24,200 $474,000
Q2 2020 Aug 18, 2020	SELL	$20.21 - $35.23 $334,071 - $582,351	-16,530 Reduced 68.31%	7,670 $263,000
Q4 2019 Feb 11, 2020	SELL	$13.39 - $20.73 $669 - $1,036	-50 Reduced 0.21%	24,200 $474,000
Q3 2019 Nov 15, 2019	SELL	$15.47 - $22.5 $51,051 - $74,250	-3,300 Reduced 11.98%	24,250 $377,000
Q2 2019 Aug 14, 2019	BUY	$15.61 - $20.44 $1,561 - $2,044	100 Added 0.36%	27,550 $559,000
Q1 2019 May 14, 2019	SELL	$13.15 - $18.71 $115,851 - $164,835	-8,810 Reduced 24.3%	27,450 $482,000
Q4 2018 Feb 13, 2019	BUY	$11.48 - $16.98 $49,651 - $73,438	4,325 Added 13.54%	36,260 $465,000
Q3 2018 Nov 14, 2018	BUY	$8.75 - $16.29 $20,125 - $37,467	2,300 Added 7.76%	31,935 $520,000
Q2 2018 Aug 10, 2018	BUY	$9.16 - $13.48 $1,328 - $1,954	145 Added 0.49%	29,635 $336,000
Q1 2018 May 17, 2018	SELL	$6.3 - $13.77 $88,200 - $192,780	-14,000 Closed	0 $0
Q4 2017 Feb 15, 2018	BUY	$3.94 - $6.64 $55,160 - $92,960	14,000	14,000 $86,000

Others Institutions Holding FATE

# of Institutions

178

Shares Held

113M

Call Options Held

53.7K

Put Options Held

Redmile Group, LLC San Francisco, CA

13.2M
Shares

$17.5 Million
3.01% of portfolio
Vanguard Group Inc Valley Forge, PA

10.4M
Shares

$13.8 Million
0.0% of portfolio
Black Rock Inc. New York, NY

10.1M
Shares

$13.5 Million
0.0% of portfolio
Deep Track Capital, LP Greenwich, CT

5.57M
Shares

$7.41 Million
0.72% of portfolio
State Street Corp Boston, MA

5.25M
Shares

$6.99 Million
0.0% of portfolio

View Full List

About FATE THERAPEUTICS INC

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $129M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

More about FATE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Doheny Asset Management /Ca, based on Form 13F filings with the SEC.

News

Stay updated on Doheny Asset Management /Ca with notifications on news.

Account